Abstract:In occidental societies, a great number of people practice sport regularly at all ages. In this context, cartilage injury incidences have become higher and higher. They are frequently diagnosed during knee arthroscopy even in asymptomatic patients. However, patients commonly present with pain, recurrent effusion, and loss of function. Concomitantly with the increasing incidence, the expectations of patients about function restore have risen as well. Since articular cartilage is characterized by a poor intrinsic regenerative capacity, treatment of these lesions is particularly challenging.Orthopedic surgeons should face this pathology not only because it is symptomatic but also for the risk of more extensive joint damage and further degeneration of the whole articular compartment.Several therapeutic strategies have been developed, both conservative and surgical. In this chapter we will focus on infiltrative therapies, such as platelet-rich plasma (PRP), mesenchymal stem cells (MSCs), and bioengineered osteochondral scaffolds.Platelet-rich plasma (PRP) is a concentrate obtained from autologous blood containing high concentrations of human platelets and platelet-derived growth factors. They are capable of modulating the early healing response and influencing inflammation, angiogenesis, and cell migration. PRP is a safe procedure, and clinical outcome is encouraging, even if it is difficult to establish PRP efficacy because authors have used different PRP formulations, with a large inter-product variability.Another powerful tool for cartilage repair emerging in recent years is mesenchymal stem cells (MSC). Their regenerative effects are due to their immunomodulatory and anti-inflammatory action but above all to their structural contribution to tissue repair. They have a capacity for self-renewal, stemness maintenance, and the marked ability to differentiate into a variety of connective tissues. MSCs can be isolated from human sources other than the bone marrow, such as adipose tissue. Studies available suggest a potential for these cell-based treatments to be developed and to represent a promising new approach with preliminary interesting findings. Nevertheless, many aspects remain to be clarified and optimized.The awareness of the involvement of the subchondral bone in many of these lesions resulted in the need to develop cell-free treatment strategies focused on the entire osteochondral unit. Therefore, surgical techniques move on from autologous chondrocyte implantation (ACI) and autograft or allograft osteochondral implantation to new bioengineered scaffolds.Ideally, a scaffold should have the following characteristics:Three-dimensional and highly porous with an interconnected pore network for cell growth and flow transport of nutrients and metabolic waste.Biocompatible and bioresorbable with a controllable degradation and resorption rate to match cell/tissue growth in vitro and/or in vivo.Suitable surface chemistry for cell attachment, proliferation, and differentiation and mechanical properties to match those of the tissues at the site of implantation.Among them MaioRegen® and, more recently, Agili-C® have shown some of the most promising results.

Absorbable Nail Fixation of Biologic Membrane for Treatment of Cartilage Defects by Matrix-Induced Autologous Chondrocyte Implantation

Current advances on surgical treatment for knee articular cartilage injuries

Adipose-derived stem cell sheet encapsulated construct of micro-porous decellularized cartilage debris and hydrogel for cartilage defect repair.

Biological Treatment in Cartilage Injuries

Acellular cartilage matrix biomimetic scaffold with immediate enrichment of autologous bone marrow mononuclear cells to repair articular cartilage defects

In Situ Cartilage Regeneration with Acellular Bone Matrix in a Preclinical Model

A new biotechnology for articular cartilage repair: subchondral implantation of a composite of interconnected porous hydroxyapatite, synthetic polymer (PLA-PEG), and bone morphogenetic protein-2 (rhBMP-2)

Use of a biological reactor and platelet-rich plasma for the construction of tissue-engineered bone to repair articular cartilage defects

One-step Strategy for Cartilage Repair Using Acellular Bone Matrix Scaffold Based in Situ Tissue Engineering Technique in a Preclinical Minipig Model.

Biphasic Double-Network Hydrogel With Compartmentalized Loading of Bioactive Glass for Osteochondral Defect Repair

Repair of Articular Osteochondral Defects Using an Integrated and Biomimetic Trilayered Scaffold.

Using a Xenogeneic Acellular Dermal Matrix Membrane to Enhance the Reparability of Bone Marrow Mesenchymal Stem Cells for Cartilage Injury.

A Study on Repair of Porcine Articular Cartilage Defects with Tissue-Engineered Cartilage Constructed in Vivo by Composite Scaffold Materials.

Biofunctionalized Structure and Ingredient Mimicking Scaffolds Achieving Recruitment and Chondrogenesis for Staged Cartilage Regeneration

Repair of osteochondral defects mediated by double-layer scaffolds with natural osteochondral-biomimetic microenvironment and interface

Recent strategies of collagen-based biomaterials for cartilage repair: from structure cognition to function endowment

Gene-activated matrices for cartilage defect reparation.

An Engineered Protein Adhesive with Properties of Tissue Integration and Controlled Release for Efficient Cartilage Repair

In Situ Cartilage Regeneration with Acellular Bone Matrix for Human Cartilage Repair

Injectable, Selfâ€�Contained, Subaqueously Crossâ€�Linking Laminous Adhesives for Biophysicalâ€�Chemical Modulation of Osteochondral Microenvironment

The Synergistic Effects of Microfracture, Perforated Decalcified Cortical Bone Matrix and Adenovirus-Bone Morphogenetic Protein-4 in Cartilage Defect Repair.